Related references
Note: Only part of the references are listed.The ingenol-based protein kinase C agonist GSK445A is a potent inducer of HIV and SIV RNA transcription
Afam A. Okoye et al.
PLOS PATHOGENS (2022)
Everolimus, an mTORC1/2 inhibitor, in ART-suppressed individuals who received solid organ transplantation: A prospective study
Timothy J. Henrich et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
Effect of rapamycin on aging and age-related diseases-past and future
Ramasamy Selvarani et al.
GEROSCIENCE (2021)
Antigen-driven clonal selection shapes the persistence of HIV-1-infected CD4(+) T cells in vivo
Francesco R. Simonetti et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
The emerging role of microRNA in regulating the mTOR signaling pathway in immune and inflammatory responses
Nazanin Nazari et al.
IMMUNOLOGY AND CELL BIOLOGY (2021)
CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification
Afam A. Okoye et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
mTOR regulates GPVI-mediated platelet activation
Longsheng Wang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2021)
Integration in oncogenes plays only a minor role in determining the in vivo distribution of HIV integration sites before or during suppressive antiretroviral therapy
John M. Coffin et al.
PLOS PATHOGENS (2021)
Rapamycin Inhibits Glioma Cells Growth and Promotes Autophagy by miR-26a-5p/DAPK1 Axis
Zheng Wang et al.
CANCER MANAGEMENT AND RESEARCH (2021)
Evaluating the Intactness of Persistent Viral Genomes in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Initiating Antiretroviral Therapy within One Year of Infection
Samuel Long et al.
JOURNAL OF VIROLOGY (2020)
The Impact of Cellular Proliferation on the HIV-1 Reservoir
Maria C. Virgilio et al.
VIRUSES-BASEL (2020)
Antigen-responsive CD4+ T cell clones contribute to the HIV-1 latent reservoir
Pilar Mendoza et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Modulation of mTORC1 Signaling Pathway by HIV-1
Burkitkan Akbay et al.
CELLS (2020)
mTOR Overcomes Multiple Metabolic Restrictions to Enable HIV-1 Reverse Transcription and Intracellular Transport
Harry E. Taylor et al.
CELL REPORTS (2020)
HIV proviral DNA integration can drive T cell growth ex vivo
John K. Yoon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Block-And-Lock: New Horizons for a Cure for HIV-1
Ines Moranguinho et al.
VIRUSES-BASEL (2020)
Thymidine kinase 1 through the ages: a comprehensive review
Eliza E. Bitter et al.
CELL AND BIOSCIENCE (2020)
Genetic Evidence That Naive T Cells Can Contribute Significantly to the Human Immunodeficiency Virus Intact Reservoir: Time to Re-evaluate Their Role
Emmanuele Venanzi Rullo et al.
CLINICAL INFECTIOUS DISEASES (2019)
Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life
Kevin O. Saunders
FRONTIERS IN IMMUNOLOGY (2019)
HIV Infected T Cells Can Proliferate in vivo Without Inducing Expression of the Integrated Provirus
Andrew Musick et al.
FRONTIERS IN MICROBIOLOGY (2019)
mTOR as a central hub of nutrient signalling and cell growth
Joungmok Kim et al.
NATURE CELL BIOLOGY (2019)
TORC1 inhibition enhances immune function and reduces infections in the elderly
Joan B. Mannick et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound
Afam A. Okoye et al.
NATURE MEDICINE (2018)
TSC1 and DEPDC5 regulate HIV-1 latency through the mTOR signaling pathway
Shan Jin et al.
EMERGING MICROBES & INFECTIONS (2018)
A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation
Daniel B. Reeves et al.
NATURE COMMUNICATIONS (2018)
Gut and blood differ in constitutive blocks to HIV transcription, suggesting tissue-specific differences in the mechanisms that govern HIV latency
Sushama Telwatte et al.
PLOS PATHOGENS (2018)
Determinants of the efficacy of HIV latency-reversing agents and implications for drug and treatment design
Ruian Ke et al.
JCI INSIGHT (2018)
Hyperactivation of mammalian target of rapamycin complex 1 by HIV-1 is necessary for virion production and latent viral reactivation
Binod Kumar et al.
FASEB JOURNAL (2017)
mTORC1 inhibition with rapamycin exacerbates adipose tissue inflammation in obese mice and dissociates macrophage phenotype from function
Vivian A. Paschoal et al.
IMMUNOBIOLOGY (2017)
Rapamycin-mediated mTOR inhibition uncouples HIV-1 latency reversal from cytokine-associated toxicity
Alyssa R. Martin et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics
Nina N. Hosmane et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Defining total-body AIDS-virus burden with implications for curative strategies
Jacob D. Estes et al.
NATURE MEDICINE (2017)
HIV-1 enhances mTORC1 activity and repositions lysosomes to the periphery by co-opting Rag GTPases
Alessandro Cinti et al.
SCIENTIFIC REPORTS (2017)
Identification of Genetically Intact HIV-1 Proviruses in Specific CD4+ T Cells from Effectively Treated Participants
Bonnie Hiener et al.
CELL REPORTS (2017)
Anti-proliferative therapy for HIV cure: a compound interest approach
Daniel B. Reeves et al.
SCIENTIFIC REPORTS (2017)
Emerging Role of MicroRNAs in mTOR Signaling
Yanjie Zhang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
mTOR Signaling in Growth, Metabolism, and Disease
Robert A. Saxton et al.
CELL (2017)
Increased glucose transporter-1 expression on intermediate monocytes from HIV-infected women with subclinical cardiovascular disease
Tiffany R. Butterfield et al.
AIDS (2017)
The mTOR Complex Controls HIV Latency
Emilie Besnard et al.
CELL HOST & MICROBE (2016)
mTOR inhibitors effects on regulatory T cells and on dendritic cells
Giovanni Stallone et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
The Enigma of Rapamycin Dosage
Suman Mukhopadhyay et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Specific miRNA Disease Biomarkers in Blood, Serum and Plasma: Challenges and Prospects
Christina Backes et al.
MOLECULAR DIAGNOSIS & THERAPY (2016)
MicroRNAs as regulatory elements in immune system logic
Arnav Mehta et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Increased Expression of CD169 on Blood Monocytes and Its Regulation by Virus and CD8 T Cells in Macaque Models of HIV Infection and AIDS
Woong-Ki Kim et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2015)
HIV-1 Integration Landscape during Latent and Active Infection
Lillian B. Cohn et al.
CELL (2015)
Induced miR-99a expression represses Mtor cooperatively with miR-150 to promote regulatory T-cell differentiation
Sebastian C. Warth et al.
EMBO JOURNAL (2015)
MicroRNA-155 Reinforces HIV Latency
Debbie S. Ruelas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies
Amanda M. Crooks et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice
Alonso Heredia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
mTOR Signaling in T Cell Immunity and Autoimmunity
Yu Liu et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2015)
Increased glucose metabolic activity is associated with CD4 R T-cell activation and depletion during chronic HIV infection
Clovis S. Palmer et al.
AIDS (2014)
Glucose Transporter 1-Expressing Proinflammatory Monocytes Are Elevated in Combination Antiretroviral Therapy-Treated and Untreated HIV+ Subjects
Clovis S. Palmer et al.
JOURNAL OF IMMUNOLOGY (2014)
microRNA regulation of mammalian target of rapamycin expression and activity controls estrogen receptor function and RADOO1 sensitivity
Elizabeth C. Martin et al.
MOLECULAR CANCER (2014)
The miR-126-VEGFR2 axis controls the innate response to pathogen-associated nucleic acids
Judith Agudo et al.
NATURE IMMUNOLOGY (2014)
mTOR Inhibition Induces Compensatory, Therapeutically Targetable MEK Activation in Renal Cell Carcinoma
Sean T. Bailey et al.
PLOS ONE (2014)
Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection
Thor A. Wagner et al.
SCIENCE (2014)
Specific HIV integration sites are linked to clonal expansion and persistence of infected cells
F. Maldarelli et al.
SCIENCE (2014)
mTOR inhibition improves immune function in the elderly
Joan B. Mannick et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Interleukin-7 promotes HIV persistence during antiretroviral therapy
Claire Vandergeeten et al.
BLOOD (2013)
Reprogramming of the MicroRNA Transcriptome Mediates Resistance to Rapamycin
Hana Totary-Jain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Different Patterns of Akt and ERK Feedback Activation in Response to Rapamycin, Active-Site mTOR Inhibitors and Metformin in Pancreatic Cancer Cells
Heloisa P. Soares et al.
PLOS ONE (2013)
MicroRNA-155 Promotes Autophagy to Eliminate Intracellular Mycobacteria by Targeting Rheb
Jinli Wang et al.
PLOS PATHOGENS (2013)
University of Modena Experience in HIV-Positive Patients Undergoing Liver Transplantation
F. Di Benedetto et al.
TRANSPLANTATION PROCEEDINGS (2011)
Targeting the Mammalian Target of Rapamycin (mTOR) in Cancer Therapy: Lessons from Past and Future Perspectives
Marc Dufour et al.
Cancers (2011)
Sirolimus immunosuppression for graft-versus-host disease prophylaxis and therapy: an update
Corey Cutler et al.
CURRENT OPINION IN HEMATOLOGY (2010)
First Report on a Series of HIV Patients Undergoing Rapamycin Monotherapy After Liver Transplantation
Fabrizio Di Benedetto et al.
TRANSPLANTATION (2010)
Gastric Mammalian Target of Rapamycin Signaling Regulates Ghrelin Production and Food Intake
Geyang Xu et al.
ENDOCRINOLOGY (2009)
Enhancing CD8 T-cell memory by modulating fatty acid metabolism
Erika L. Pearce et al.
NATURE (2009)
mTOR regulates memory CD8 T-cell differentiation
Koichi Araki et al.
NATURE (2009)
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
Nicolas Chomont et al.
NATURE MEDICINE (2009)
Monotherapy rapamycin allows an increase of CD4+ CD25bright+ FoxP3+ T cells in renal recipients
Thijs K. Hendrikx et al.
TRANSPLANT INTERNATIONAL (2009)
Rhesus macaque rhadinovirus-associated non-Hodgkin lymphoma: animal model for KSHV-associated malignancies
Beata U. Orzechowska et al.
BLOOD (2008)
Improved Survival in Lymphoma Patients Receiving Sirolimus for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation With Reduced-Intensity Conditioning
Philippe Armand et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy
Tae-Wook Chun et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Sialoadhesin (CD169) Expression in CD14+Cells Is Upregulated Early after HIV-1 Infection and Increases during Disease Progression
Antoinette C. van der Kuyl et al.
PLOS ONE (2007)
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Jason M. Brenchley et al.
NATURE MEDICINE (2006)
Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T cells
Danila Valmori et al.
JOURNAL OF IMMUNOLOGY (2006)
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
DD Sarbassov et al.
MOLECULAR CELL (2006)
mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt
KE O'Reilly et al.
CANCER RESEARCH (2006)
Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines
Fanyin Meng et al.
GASTROENTEROLOGY (2006)
Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells
M Battaglia et al.
BLOOD (2005)
Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV β-chemokines:: An approach to suppress R5 strains of HIV-1
A Heredia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
JD Siliciano et al.
NATURE MEDICINE (2003)
Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients
JD Morrisett et al.
TRANSPLANTATION PROCEEDINGS (2003)
Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients
JD Morrisett et al.
JOURNAL OF LIPID RESEARCH (2002)
The IgG Fc contains distinct Fc receptor (FcR) binding sites:: The leukocyte receptors FcγRI and FcγRIIa bind to a region in the Fc distinct from that recognized by neonatal FcR and protein A
BD Wines et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
